期刊文献+

多发性骨髓瘤轻链型与非轻链型实验室检查结果比较 被引量:4

Comparison of the laboratory test results of light chain and non- light chain multiple myeloma
原文传递
导出
摘要 目的评估并比较初治轻链型与非轻链型多发性骨髓瘤(MM)患者实验室检查各指标异常情况。方法比较本院自2011年1月-2016年1月共105例初治轻链型与非轻链型MM患者各实验室检查结果(轻链型31例,非轻链型74例)。结果轻链型患者中Cr水平及异常比例明显高于非轻链型,差异有统计学意义(P=0.03),而轻链型Cys-C水平与非轻链型差异无统计学意义(P=0.57)。轻链型患者原始和幼稚浆/总浆高于非轻链型,差异有统计学意义(P=0.02)。轻链型患者的LDH、β_2M和ALB水平明显高于非轻链型,差异有统计学意义(P<0.05),而ISS分期差异无统计学意义(P=0.38)。结论轻链型患者初诊时肿瘤负荷更大,疾病进展可能更快。 Objective To evaluate and compare the abnormality of the laboratory test results of newly diagnosed light chain and non- light chain multiple myeloma( MM). Methods The laboratory test results of 105 newly diagnosed light chain( n = 31)and non- light chain( n = 74) multiple myeloma patients admitted into our hospital from January 2011 to January 2016 were evaluated and compared. Results Light chain type patients had significantly higher creatinine level and abnormal percentage than non- light chain type patients,with the difference statistically significant( P = 0. 03),while the cystatin- C level of light chain type patients had no difference with the non- light chain type patients( P = 0. 57). The ratio of plasmablasts and proplasmacytes / all plasmacytic cells in light chain type patients were significantly higher than non- light chain type patients,with the differences statistically significant( P = 0. 02). Light chain type patients also had significantly higher LDH,β2M and ALB level than non- light chain type patients,with the differences not statistically significant( P〈0. 05),while there was no statistical significance on the the difference in ISS( P = 0. 38). Conclusion In newly diagnosed patients,light chain type patients have heavier tumor burden and may progress faster than non- light chain type multiple myeloma patients.
出处 《中国卫生检验杂志》 CAS 2016年第15期2144-2146,共3页 Chinese Journal of Health Laboratory Technology
关键词 多发性骨髓瘤 生化分析 骨髓 免疫球蛋白轻链 Multiple myeloma Biochemical analysis Bone marrow Immunoglobulin light chain
  • 相关文献

参考文献15

  • 1Kyle RA, Rajkumar SV. Multiple rnyeloma[J]. N Engl J Med, 2004, 351 (18) : 1860 - 1873.
  • 2Greipp PR, Jesus SM, Durie BGM, et al. Interna/ionstaging sys- tem for multiple myeloma [ J ]. J Clin Oncol, 2005,23 ( 15 ) : 3412 - 3420.
  • 3翟玉华.轻链型多发性骨髓瘤免疫分型及意义[J].现代检验医学杂志,2007,22(1):22-23. 被引量:9
  • 4Hutchison CA, Batuman V, Behrens J, et al. The pathogenesis and diagnosis of acute kidney inju in multiple mycloma[ J]. Nat Rev Nephrol, 2011, 8( 1 ) : 43 -51.
  • 5Dhamidharka VR, Kwon C, Stevens G. Serum cystatin C is superi- or to serum creatinine as a marker of kidney function : a meta - a- nalysis[J]. Am J Kidney Dis, 2002, 40(2): 221 -226.
  • 6Roos JF, Doust J, Tett SE, et al. Diagnostic acmlracy of eystatin C compared to serum m'eatinine for the estimation of renal dysflmction in adults and children -a meta- analysis [ J ]. Clin Bioehem, 2007, 40(5/6) : 383 -391.
  • 7Durie BGM, Salmon SE. A clinical stagingsystem for multiple mye- loma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival[ J]. Cancer, 1975, 36 ( 3 ) : 842 - 854.
  • 8苏畅,罗绍凯,许丽梅,颜棉生.轻链型多发性骨髓瘤23例临床分析[J].中国全科医学,2004,7(18):1308-1309. 被引量:20
  • 9Palumbo A, Avet- Loiseau H, Oliva S, et al. Revised internation- al staging system for multiple myeloma: A report fi'om intenaational myeloma working group [J ]. J Clin Oneol, 2015,33 (26) : 2863 - 2869.
  • 10张曦,常春康,吴凌云,周立宇,苏基滢,李晓.多发性骨髓瘤患者白蛋白校正后高血钙发生率的研究[J].诊断学理论与实践,2010,9(3):233-235. 被引量:7

二级参考文献39

共引文献66

同被引文献21

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部